TAKEDA PHARMACEUTICAL COMPANY

Lobbying Spend

—

Filings

Firms Hired

Active Period

2025–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	1	1
2025	—	5	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MR. BRIAN KELLY	—	6

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Commerce, Dept of (DOC)	4
HOUSE OF REPRESENTATIVES	4
SENATE	4
U.S. Trade Representative (USTR)	4
White House Office	4

Most frequently reported lobbying issues

Issue Code	Description	Reports
Tariff (miscellaneous tariff bills)	Tariff (miscellaneous tariff bills)	5
Trade (domestic/foreign)	Trade (domestic/foreign)	5
Pharmacy	Pharmacy	5
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	4
Health Issues	Health Issues	1

TAKEDA PHARMACEUTICAL COMPANY — Lobbying Disclosure | Poliscope